PDB80 WHICH OUTCOME QUALITY MEASURES DO LEADING KOLS WHO TREAT NONALCOHOLIC STEATOHEPATITIS (NASH) RECOMMEND FOR VALUE-BASED CONTRACTING ACROSS MULTIPLE STAKEHOLDERS?
May 1, 2019, 00:00
10.1016/j.jval.2019.04.629
https://www.valueinhealthjournal.com/article/S1098-3015(19)30821-6/fulltext
Title :
PDB80 WHICH OUTCOME QUALITY MEASURES DO LEADING KOLS WHO TREAT NONALCOHOLIC STEATOHEPATITIS (NASH) RECOMMEND FOR VALUE-BASED CONTRACTING ACROSS MULTIPLE STAKEHOLDERS?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)30821-6&doi=10.1016/j.jval.2019.04.629
First page :
Section Title :
Open access? :
No
Section Order :
10250